Mar 16, 2022 / 07:20PM GMT
Steven Michael Lichtman - Oppenheimer & Co. Inc., Research Division - MD & Senior Analyst
Hi, everyone. I'm Steve Lichtman, medical devices analyst at Oppenheimer. Welcome to the 32nd Annual Oppenheimer Healthcare Conference.
Up next for us, I'm very happy to have the Cooper Companies. With us is Brian Andrews, Executive Vice President, CFO and Treasurer. We're going to do a fireside chat format. If you do have any questions, please key them in, and I will get them over to Brian. With that, Brian, thanks for joining us today.
Brian G. Andrews - The Cooper Companies, Inc. - Executive VP, CFO & Treasurer
Happy to be here, Steve. Thanks for having me.
Questions and Answers:
Steven Michael Lichtman - Oppenheimer & Co. Inc., Research Division - MD & Senior AnalystSo I thought we just sort of set the scene on the CDI side of your business. And wondering if you could lay out for investors where you think penetration sits on some of the key opportunities, including silicone hydrogel,